Paper35623638
The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist.
Romano M and 30 others. Ann Rheum Dis, 2022. Cited by 101 papers, by iCite.
Cite this record
ConductScience Library. The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist. Papers, record 35623638. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35623638
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cryopyrin-Associated Periodic Syndromes | Major topic |
| Hereditary Autoinflammatory Diseases | Major topic |
| Mevalonate Kinase Deficiency | Major topic |
| Rheumatology | Major topic |
| Fever | |
| Humans | |
| Interleukin 1 Receptor Antagonist Protein | |
| Interleukin-1 | |
| Quality of Life | |
| Receptors, Interleukin-1 |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| ZIAAI001220 | NIH | NIH RePORTER | |||
| ZIAHG200371 | NIH | NIH RePORTER | |||
| ZIAHG200372 | NIH | NIH RePORTER | |||
| ZIAHG200373 | NIH | NIH RePORTER |
Cited by71
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 101 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42872043 | Combined interleukin-1 blockade for central nervous system inflammation in children with severe cryopyrin-associated periodic syndromes. | EULAR Rheumatol Open | 2026 | https://conductscience.org/library/papers/42872043 | PubMed |
| 42745142 | How Organ Manifestations Beyond the Bone May Guide Risk Stratification and Treatment Decisions in Chronic Nonbacterial Osteomyelitis. | Paediatr Drugs | 2026 | https://conductscience.org/library/papers/42745142 | PubMed |
| 42730335 | Nanomaterial-Based Strategies Targeting IL-1 Signalling in Inflammatory Bowel Disease: Therapeutic Applications and Mechanistic Insights. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/42730335 | PubMed |
| 42691741 | Biologic-biologic and biologic-JAK inhibitor combination therapy in refractory systemic autoinflammatory diseases. | Semin Arthritis Rheum | 2026 | https://conductscience.org/library/papers/42691741 | PubMed |
| 42650168 | Chronic Urticaria-Associated Syndromes: Is Andersen-Tawil Syndrome One of Them? | Genes (Basel) | 2026 | https://conductscience.org/library/papers/42650168 | PubMed |
| 42539949 | Living with a systemic autoinflammatory disease: burden of disease and effects on quality of life-an international patient survey. | EULAR Rheumatol Open | 2026 | https://conductscience.org/library/papers/42539949 | PubMed |
| 42346291 | Pro-Inflammatory Synergy Between IL-17, IL-1 and Hyperuricemia in Psoriatic Arthritis: Clinical Implications of a Pilot Study. | Diseases | 2026 | https://conductscience.org/library/papers/42346291 | PubMed |
| 42310657 | The use of JAK inhibitors and tocilizumab in the management of TRAPS: a sibling case study. | Pediatr Rheumatol Online J | 2026 | https://conductscience.org/library/papers/42310657 | PubMed |
| 42278349 | Mitochondrial Regulation of the NLRP3 Inflammasome in Diabetic Kidney Disease: From Mechanisms to Therapeutic Strategies. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42278349 | PubMed |
| 41965684 | Genotype-phenotype correlations in pediatric CAPS with predominantly low-penetrance NLRP3 variants among Turkish patients in Germany and Turkey: beyond borders. | Pediatr Rheumatol Online J | 2026 | https://conductscience.org/library/papers/41965684 | PubMed |
| 41680868 | Pharmacologic management of renal involvement in monogenic autoinflammatory diseases. | Eur J Med Res | 2026 | https://conductscience.org/library/papers/41680868 | PubMed |
| 41466287 | Prevalence estimation of a rare disease with the French National Rare Disease Registry: example of TNF receptor associated periodic syndrome (TRAPS). | Orphanet J Rare Dis | 2025 | https://conductscience.org/library/papers/41466287 | PubMed |
| 41451028 | Neonatal familial cold autoinflammatory syndrome: A newborn with recurrent cold-induced urticarial eruptions. | JAAD Case Rep | 2026 | https://conductscience.org/library/papers/41451028 | PubMed |
| 41221292 | The ATP-mediated cytokine release by macrophages is down-modulated by unconventional α9* nicotinic acetylcholine receptors. | Front Immunol | 2025 | https://conductscience.org/library/papers/41221292 | PubMed |
| 41206040 | Modulating NLRP3 splicing with antisense oligonucleotides to control pathological inflammation. | Nucleic Acids Res | 2025 | https://conductscience.org/library/papers/41206040 | PubMed |
| 41168503 | ZNF334 truncation mutation drives cold-induced autoinflammation. | EMBO Mol Med | 2025 | https://conductscience.org/library/papers/41168503 | PubMed |
| 41127878 | Role of T cells and cytokines in the pathogenesis of rheumatoid arthritis. | Biochem Biophys Rep | 2025 | https://conductscience.org/library/papers/41127878 | PubMed |
| 41113563 | Clinical and genetic analysis of Majeed syndrome caused by LPIN2 complex heterozygous mutation and literature review. | Front Pediatr | 2025 | https://conductscience.org/library/papers/41113563 | PubMed |
| 41020641 | TNF Receptor-Associated Periodic Syndrome: An Analysis of a Slovakian Cohort of TRAPS Patients. | Arch Rheumatol | 2025 | https://conductscience.org/library/papers/41020641 | PubMed |
| 40873778 | A Comprehensive Clinical Evaluation of Rilonacept in the Treatment of Recurrent Pericarditis: A Systematic Review. | J Inflamm Res | 2025 | https://conductscience.org/library/papers/40873778 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IL1A | 3552 | PubTator's text mining | https://conductscience.org/library/genes/3552 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35623638
GET https://conductscience.org/api/papers/v1/35623638/authors?page=2